Dhawan U, Tseng C-L, Wu P-H, Liao M-Y, Wang H-Y, Wu KC-W, Chung R-J
In order to make GLP-1 better used in the clinic, drug developers modified its structure and developed a series of GLP-1R agonists ( GLP-1, a 30- or 31-amino-acid-long peptide hormone, is a gastrointestinal peptide secreted by the intestinal tract that potentiates insulin release and reduces glucagons concentration in physiological conditions ( Scheme 1
3 Week 24 Early Effects First changes noticed sleep quality, energy, and recovery common early signals
The active ingredient in compounded semaglutide is the same molecule that Novo Nordisk sells as Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes, prescribed off-label for weight loss)
Many patients who plateau on Semaglutide already switch to Tirzepatide successfully